Meyer GJ - Search Results

1

Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.

Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH. Otto D, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1405-12. doi: 10.1007/s00259-004-1610-1. Epub 2004 Jul 29. Eur J Nucl Med Mol Imaging. 2004. PMID: 15278308 Clinical Trial.

2

[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.

Berding G, Schrader CH, Peschel T, van den Hoff J, Kolbe H, Meyer GJ, Dengler R, Knapp WH. Berding G, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):127-31. doi: 10.1007/s00259-002-1019-7. Epub 2002 Nov 9. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483420 Clinical Trial.

3

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.

Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Pötter E. Petrich T, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):842-54. doi: 10.1007/s00259-002-0784-7. Epub 2002 Apr 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 12111124

4

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.

Fricke E, Machtens S, Hofmann M, van den Hoff J, Bergh S, Brunkhorst T, Meyer GJ, Karstens JH, Knapp WH, Boerner AR. Fricke E, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):607-11. doi: 10.1007/s00259-002-1104-y. Epub 2003 Feb 13. Eur J Nucl Med Mol Imaging. 2003. PMID: 12589476 Clinical Trial.

5

In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin.

Petrich T, Korkmaz Z, Krull D, Frömke C, Meyer GJ, Knapp WH. Petrich T, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2010 May;37(5):851-61. doi: 10.1007/s00259-009-1356-x. Epub 2010 Jan 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20107790

6

[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET.

van den Hoff J, Burchert W, Börner AR, Fricke H, Kühnel G, Meyer GJ, Otto D, Weckesser E, Wolpers HG, Knapp WH. van den Hoff J, et al. Among authors: meyer gj. J Nucl Med. 2001 Aug;42(8):1174-82. J Nucl Med. 2001. PMID: 11483676 Free article. Clinical Trial.

7

Dopamine D2 receptor imaging in Gilles de la Tourette syndrome.

Müller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, Knapp WH, Emrich HM. Müller-Vahl KR, et al. Among authors: meyer gj. Acta Neurol Scand. 2000 Mar;101(3):165-71. doi: 10.1034/j.1600-0404.2000.101003165.x. Acta Neurol Scand. 2000. PMID: 10705938

8

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.

Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Göke B, Morris JC, Spitzweg C. Willhauck MJ, et al. Among authors: meyer gj. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1272-81. doi: 10.1007/s00259-008-0775-4. Epub 2008 Apr 11. Eur J Nucl Med Mol Imaging. 2008. PMID: 18404268

9

Dopamine transporter binding in Gilles de la Tourette syndrome.

Müller-Vahl KR, Berding G, Brücke T, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, Knapp WH, Emrich HM. Müller-Vahl KR, et al. Among authors: meyer gj. J Neurol. 2000 Jul;247(7):514-20. doi: 10.1007/pl00007806. J Neurol. 2000. PMID: 10993492

10

Serotonin transporter binding in Tourette Syndrome.

Müller-Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brücke T, Berding G. Müller-Vahl KR, et al. Among authors: meyer gj. Neurosci Lett. 2005 Sep 9;385(2):120-5. doi: 10.1016/j.neulet.2005.05.031. Neurosci Lett. 2005. PMID: 15936877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page